Your browser doesn't support javascript.
loading
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
Visco, Carlo; Tisi, Maria C; Evangelista, Andrea; Di Rocco, Alice; Zoellner, Anna-Katharina; Zilioli, Vittorio R; Hohaus, Stefan; Sciarra, Roberta; Re, Alessandro; Tecchio, Cristina; Chiappella, Annalisa; Morello, Lucia; Gini, Guido; Nassi, Luca; Perrone, Tommasina; Molinari, Anna L; Fabbri, Alberto; Cox, Maria C; Finolezzi, Erica; Ferrero, Simone; Puccini, Benedetta; Alvarez De Celis, Isabel; Arcari, Annalisa; Marino, Dario; Merli, Michele; Piazza, Francesco; Gentile, Massimo; Pelosini, Matteo; Loseto, Giacomo; Hermine, Olivier; Dreyling, Martin; Ruggeri, Marco; Martelli, Maurizio; Hoster, Eva; Vitolo, Umberto.
Afiliación
  • Visco C; Haematology, San Bortolo Hospital, Vicenza, Italy.
  • Tisi MC; Haematology, San Bortolo Hospital, Vicenza, Italy.
  • Evangelista A; Clinical Epidemiology, Città della Salute e della Scienza and CPO Piemonte, Torino, Italy.
  • Di Rocco A; Cellular Biotechnologies and Haematology, 'Sapienza' University, Rome, Italy.
  • Zoellner AK; Medical Department III, University Hospital Munich, Munich, Germany.
  • Zilioli VR; Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Hohaus S; Policlinico Gemelli Foundation, Institute of Haematology, Catholic University of the Sacred Heart, Rome, Italy.
  • Sciarra R; Haematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Re A; Haematology, Spedali Civili, Brescia, Italy.
  • Tecchio C; Medicine, Section of Haematology and Bone Marrow Transplant Unit, University of Verona, Verona, Italy.
  • Chiappella A; Haematology, Citta' della salute e della scienza university hospital, Torino, Italy.
  • Morello L; Haematology, Humanitas Clinical and Research Center, Rozzano, Italy.
  • Gini G; Haematology Clinic, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Nassi L; Haematology Department, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
  • Perrone T; Department of Emergency and Organ Transplantation, Haematology Section, University of Bari, Bari, Italy.
  • Molinari AL; Haematology, Ospedale degli Infermi, Rimini, Italy.
  • Fabbri A; Unit of Haematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
  • Cox MC; Haematology unit, AOU Sant'Andrea, Rome, Italy.
  • Finolezzi E; Haematology, Transfusional Medicine and Biotechnologies, UOSD "Centro Diagnosi e Terapia dei Linfomi", PO Santo Spirito, Pescara, Italy.
  • Ferrero S; Molecular Biotechnologies and Health Sciences, University of Torino/AOU "Città della Salute e della Scienza di Torino", Torino, Italy.
  • Puccini B; Haematology, University of Firenze, Firenze, Italy.
  • Alvarez De Celis I; Haematology Unit, AUSLL/IRCCS Santa Maria Nuova Hospital, Reggio Emilia, Italy.
  • Arcari A; Haematology and Bone Marrow Transplant Unit, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Marino D; Medical Oncology 1, Veneto Institute of Oncology IOV IRCCS, Padova, Italy.
  • Merli M; Haematology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy.
  • Piazza F; Haematology, Department of Medicine, University of Padova, Padova, Italy.
  • Gentile M; Onco-haematology, Haematology Unit, AO of Cosenza, Cosenza, Italy.
  • Pelosini M; Clinical and Experimental Medicine, Section of Haematology, University of Pisa, Pisa, Italy.
  • Loseto G; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Hermine O; Clinical Haematology, Université Sorbonne Paris Cité, Hôpital Necker, Paris, France.
  • Dreyling M; Medical Department III, University Hospital Munich, Munich, Germany.
  • Ruggeri M; Haematology, San Bortolo Hospital, Vicenza, Italy.
  • Martelli M; Cellular Biotechnologies and Haematology, 'Sapienza' University, Rome, Italy.
  • Hoster E; Medical Department III, University Hospital Munich, Munich, Germany.
  • Vitolo U; Haematology, Citta' della salute e della scienza university hospital, Torino, Italy.
Br J Haematol ; 185(5): 940-944, 2019 06.
Article en En | MEDLINE | ID: mdl-30407625
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células del Manto / Citarabina / Antimetabolitos Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células del Manto / Citarabina / Antimetabolitos Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia